1. Association study between ZFHX3 gene polymorphisms and obesity in Korean population
    Seung-Ae Yang, 2017, J Exerc Rehabil CrossRef
  2. Protein kinase Cβ activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation
    Haoran Tai et al, 2017, The FASEB Journal CrossRef
  3. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation
    Shun Zhou et al, 2018, Mol Carcinog CrossRef
  4. m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.
    Jiqin Liu et al, 2018, Biochem Biophys Res Commun CrossRef
  5. Critical Enzymatic Functions of FTO in Obesity and Cancer
    Xiaolan Deng et al, 2018, Front. Endocrinol. CrossRef
  6. Oestrogen receptor α regulates the odonto/osteogenic differentiation of stem cells from apical papilla via ERK and JNK MAPK pathways
    Yanqiu Wang et al, 2018, Cell Prolif CrossRef
  7. Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progression
    JiaLing Chen et al, 2018, J Cancer Res Clin Oncol CrossRef
  8. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer
    Ai Liu et al, 2019, J Cell Biochem CrossRef
  9. New sights in cancer: Component and function of N6-methyladenosine modification
    Yiyang Hu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  10. The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer
    Monika Sobočan et al, 2020, Cancers CrossRef
  11. Association between FTO gene polymorphisms and breast cancer: the role of estrogen
    Maryam Gholamalizadeh et al, 2020, Expert Review of Endocrinology & Metabolism CrossRef
  12. The impact of genetic polymorphisms on weight regain after successful weight loss
    Chanisa Thonusin et al, 2020, Br J Nutr CrossRef
  13. Influence of YKL-40 gene RNA interference on the biological behaviors of endometrial cancer HEC-1A cells.
    Lili Li et al, 0 CrossRef
  14. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway
    Lin zhang et al, 2020, RNA Biology CrossRef
  15. RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
    Chang Gu et al, 2020, The Innovation CrossRef
  16. The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers


    Jin-yan Wang et al, 2020, OTT CrossRef
  17. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
    Chengquan Shen et al, 2021, Front. Endocrinol. CrossRef
  18. Exploring diagnostic m6A regulators in endometriosis
    Li Jiang et al, 2020, Aging CrossRef
  19. A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer
    Hajar Ku Yasin et al, 2021, Cancers CrossRef
  20. Effects of m6A RNA methylation regulators on endometrial cancer
    Yanli Zhang et al, 2021, J Clin Lab Anal CrossRef
  21. Targeting the RNA demethylase FTO for cancer therapy
    Lin-Lin Zhou et al, 2021, RSC Chem. Biol. CrossRef
  22. Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
    Qing-Kang Zheng et al, 2021, OTT CrossRef
  23. The Role of FTO in Tumors and Its Research Progress
    Hao Wei et al, 2022, CMC CrossRef
  24. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Hidde R Zuidhof et al, 2022, Cancer Res CrossRef
  25. RNA m 6 A methylation in cancer
    Zhaotong Wang et al, 2022, Molecular Oncology CrossRef
  26. Targeting FTO Suppresses Pancreatic Carcinogenesis via Regulating Stem Cell Maintenance and EMT Pathway.
    Rachana Garg et al, 2022, Cancers (Basel) CrossRef
  27. Androgens in endometrial carcinoma: the killer or helper?
    X. Wu et al, 2022, J Endocrinol Invest CrossRef
  28. FTO regulates the DNA damage response via effects on cell-cycle progression
    Weiying Liu et al, 2023, Mutation Research/Genetic Toxicology and Environmental Mutagenesis CrossRef
  29. Effect of demethyltransferase FTO on tumor progression
    LING SHENG et al, 2022 CrossRef
  30. FTO: a critical role in obesity and obesity-related diseases
    Dan Yin et al, 2023, Br J Nutr CrossRef
  31. The emerging function of N6-methyladenosine and its regulators in endometrial cancer; Current knowledge and prospect
    Maryam Rabiei et al, 2023, Human Gene CrossRef
  32. Roles of estrogen receptor α in endometrial carcinoma (Review)
    Yidong Ge et al, 2023, Oncol Lett CrossRef
  33. The role of the m6A/m demethylase FTO in memory is both task and sex-dependent in mice
    A.M. Leonetti et al, 2024, Neurobiology of Learning and Memory CrossRef
  34. Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
    Junchen Guo et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  35. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms
    Sarah Kassem Azzam et al, 2022, IJMS CrossRef
  36. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
    Yazhen You et al, 2022, IJMS CrossRef
  37. Research progress on m6A demethylase FTO and its role in gynecological tumors
    SiYuan Wang et al, 2024, Front. Oncol. CrossRef
  38. Meta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer
    Ciba Zhu et al, 2024 CrossRef
  39. Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications
    Akshat D. Modi et al, 2024, Expert Rev. Mol. Med. CrossRef
  40. Comparative transcriptomic and metabolomic analysis of FTO knockout and wild-type porcine iliac artery endothelial cells
    Libao Xie et al, 2024, Gene CrossRef
  41. mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells
    Muhammet Volkan Bulbul et al, 2024, Pharmaceuticals CrossRef
  42. Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
    Manel Albertí-Valls et al, 2024, Cancers CrossRef